NASA Public Affairs Officer Brandi Dean talks with Dr. David Klaus,
principal investigator for Antibiotic Effectiveness in Space from
BioServe Space Technologies, University of Colorado. Klaus discusses the
NPL Vacccine-21 experiment that is being sent to the International
Space Station aboard the Cygnus commercial cargo craft this month.
No comments:
Post a Comment